Aveanna Healthcare Holdings Inc. — Form 8-K Summary
Business Context and Reporting Period
Aveanna Healthcare Holdings Inc. filed a Form 8-K dated December 11, 2023, reporting a management appointment and related compensation arrangements. The company’s common stock trades on Nasdaq under the symbol AVAH.
Material Corporate Event
Effective January 1, 2024, the Board appointed Matthew Buckhalter, then serving as Interim Chief Financial Officer and Principal Financial Officer, as Chief Financial Officer and Principal Financial Officer.
Mr. Buckhalter has been with Aveanna for more than seven years and has held finance, financial planning and analysis, investor relations, and interim CFO responsibilities. He has more than a decade of healthcare finance experience.
Compensation and Financial Information
- Base salary: $425,000 per year.
- Annual target bonus opportunity: 75% of base salary.
- Continued participation in the company’s long-term equity incentive program.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide financial guidance, an operating outlook, material risk updates, contingencies, or unusual financial items. It states that there are no arrangements or understandings with other persons relating to Mr. Buckhalter’s appointment, no applicable family relationships, and no reportable related-party transactions under Item 404(a) of Regulation S-K.
A press release announcing the appointment was furnished under Item 7.01 as Exhibit 99.1 and is not treated as filed for purposes of Section 18 of the Exchange Act.
Key Facts for Investors to Verify
- Confirm the January 1, 2024 effective date of Mr. Buckhalter’s permanent CFO appointment.
- Review Exhibit 99.1 for management’s additional comments regarding the appointment.
- Assess the effect of the new compensation package, including the target bonus and ongoing equity participation, in subsequent filings.
- Use the company’s periodic reports for financial performance, leverage, liquidity, guidance, and risk disclosures, which are not provided in this filing.